QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TARS

QT67Tarsus Pharmaceuticals, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
63.16
+0.61+0.98%
OverviewShort InterestFilings
TARSQT67Tarsus Pharmaceuticals, Inc.·NASDAQ
OverviewShort InterestFilings
63.16+0.98%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.14
Insider Own5.95%
Shs Outstand43.02M
Perf Week0.88%
Market Cap2.69BForward P/E20.82EPS next Y3.03Insider Trans0.68%Shs Float-Perf Month3.05%
Enterprise Value2.68BPEG-EPS next Q-0.22Inst Own-Short Float-Perf Quarter-5.38%
Income-48440675.00P/S5.03EPS this Y45.69%Inst Trans-Short Ratio-Perf Half Y-19.32%
Sales535.08MP/B7.70EPS next Y590.05%ROA-8.31%Short Interest-Perf YTD-22.86%
Book/sh8.11P/C-EPS next 5Y-ROE-14.19%52W High85.25 -25.91%Perf Year60.22%
Cash/sh9.04P/FCF-EPS past 3/5Y-ROIC-11.54%52W Low38.51 64.01%Perf 3Y-
Dividend Est.-EV/EBITDA-66.64Sales past 3/5Y158.86% -Gross Margin90.44%Volatility2.28% 2.83%Perf 5Y-
Dividend TTM-EV/Sales5.00EPS Y/Y TTM62.87%Oper. Margin-9.50%ATR (14)2.77Perf 10Y-
Dividend Ex-Date-Quick Ratio3.71Sales Y/Y TTM192.90%Profit Margin-9.02%RSI (14)54.83Recom2.33
Dividend Gr. 3/5Y-Current Ratio3.74EPS Q/Q75.00%SMA203.88%Beta0.77Target Price68.00
Payout0.00%Debt/Eq0.25Sales Q/Q107.69%SMA50-0.12%Rel Volume0.63Prev Close62.55
Employees323LT Debt/Eq0.27EarningsAug 06SMA200-7.47%Avg Volume642.29KPrice63.16
IPO DateOct 16, 2020Option/ShortYes / YesEPS/Sales Surpr.60.17% 8.00%Net Debt/EBITDA0.34Volume402,143Change0.98%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-05-26ReiteratedGoldman SachsNeutral$51 → $68
Dec-08-25InitiatedBarclaysOverweight$62 → $100
Nov-20-25InitiatedMizuhoOutperform$100
Nov-06-25ReiteratedGoldman SachsNeutral$45 → $51
Oct-20-25ReiteratedH.C. Wainwright$72 → $88
May-02-25ReiteratedGuggenheimBuy$84
Mar-06-25ReiteratedJefferiesBuy$58
Jan-27-25ReiteratedBarclaysOverweight$62
Jan-22-25ReiteratedOppenheimerOutperform$63 → $72
Sep-23-24ReiteratedOppenheimerOutperform$63
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue536451183
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A513113
Gross Profit484421170
Selling, General and Administrative Excl. Other479427237
Research and Development726453
Other Operating Expense-1511
Operating Income-51-71-121
Interest Expense897
Unusual Expense
———
Non-Operating Income (Expense)-9-16-13
Net Income Before Taxes-48-64-116
Income Taxes020
Consolidated Net Income-48-66-116
Net Income From Continuing Operations-48-66-116
Net Income-48-66-116
EPS (Recurring)-1.14-1.59-3.07
EPS (Basic, Before Extraordinaries)-1.14-1.59-3.07
EPS (Diluted)-1.14-1.59-3.07
EBITDA-41-54-106
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.077.63—
Gross Margin90.3093.3592.90
Operating Margin-9.51-15.74-66.12
Net Margin-8.96-14.63-63.39
Shares Outstanding434238
Market Capitalization2,7163,439—
Operating Lease Expense
———
Insider Trading Volume
$70.76$64.23$57.70$51.18$44.65● Close Price0.00M1.98M3.97M5.95M7.94MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Farrow Jeffrey SSee RemarksJun 16 '26Sale60.9514,396877,43656,801Jun 17 12:00 AM
LINK WILLIAM J PHDDirectorJun 15 '26Sale62.1212,500776,495106,786Jun 17 12:00 AM
Goodrich KatherineDirectorJun 15 '26Sale62.082,954183,3842,233Jun 17 12:00 AM
Farrow Jeffrey SSee RemarksJun 15 '26Option Exercise0.0055,762071,197Jun 17 12:00 AM
LINK WILLIAM J PHDDirectorJun 12 '26Option Exercise0.005,9080119,286Jun 16 12:00 AM
CHAUDHURI BHASKARDirectorJun 12 '26Option Exercise0.005,908011,654Jun 16 12:00 AM
Goodrich KatherineDirectorJun 12 '26Option Exercise0.005,90805,187Jun 16 12:00 AM
Goldberg Andrew D.DirectorJun 12 '26Option Exercise0.005,908019,654Jun 16 12:00 AM
YARNO WENDY LDirectorJun 12 '26Option Exercise0.005,908016,654Jun 16 12:00 AM
Morrison Scott WDirectorJun 12 '26Option Exercise0.005,90807,638Jun 16 12:00 AM
PYOTT DAVID E IDirectorApr 24 '26Option Exercise0.002,76601,383Apr 28 12:00 AM
Neervannan SeshadriChief Operating OfficerMar 20 '26Sale66.752,989199,51682,791Mar 24 12:00 AM
Wahl BryanGeneral CounselMar 19 '26Sale67.004,231283,47763,959Mar 19 12:00 AM
Farrow Jeffrey SSee RemarksMar 19 '26Sale67.002,186146,46243,316Mar 19 12:00 AM
Whitfield Dianne C.Chief Human Resources OfficerMar 19 '26Sale67.004,174279,65835,028Mar 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR